Concepedia

S. Tafuto

ST

3

Publications

132

Citations

3

H-Index

2014

Active since

Affiliations

University of Rome Tor Vergata(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Ospedaliera San Gerardo

Azienda Ospedaliera G.Rummo

University of Cagliari

S. Tafuto is an author at University of Rome Tor Vergata specializing in pharmacology, medicine, and oncology.

Top concepts

MedicineOncologyPharmacologyCancer TherapyCancer ResearchPharmacotherapyClinical TrialsGastroenterologySurgical OncologyRadiation Oncology

Publications per year

2014–2022

3

Publications

3

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 89 citations · Full text

Surgical Oncology, Oncology, Gastrointestinal Oncology +10

LBA45 Randomized open label phase III study comparing the efficacy and safety of everolimus followed by chemotherapy (CT) with streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs: The SEQTOR study (GETNE 1206)

Ramón Salazar, S. Tafuto, Merete Krogh et al. · Annals of Oncology · 2022 · 30 citations · Full text

Advanced Progressive Pannets, Seqtor Study, Reverse Sequence +11

Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer

Maria Di Bartolomeo, Filippo Pietrantonio, Eliana Rulli et al. · Tumori Journal · 2016 · 13 citations

Rows per page

1–3 of 3